Lancet
-
Biography Historical Article
Kerin O'Dea: improving the health of Indigenous Australians.
-
Randomized Controlled Trial Multicenter Study
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
New drugs, but also shorter, better-tolerated regimens are needed to tackle the high global burden of tuberculosis complicated by drug resistance and retroviral disease. We investigated new multiple-agent combinations over the first 14 days of treatment to assess their suitability for future development. ⋯ The Global Alliance for TB Drug Development (TB Alliance).